Compare Medpace Holdings Inc (MEDP) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Invesco NASDAQ 100 ETF — how do they compare? Medpace Holdings Inc trades at $528.29 (market cap $15.08B), while Invesco NASDAQ 100 ETF trades at $290.95. Which is the better fit depends on your goals.
| MEDP | QQQM | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $620.59 | $307.23 |
52-Week Low | $308.88 | $228.02 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
QQQM trades at $286.58 with minimal daily movement (+0.09%), reflecting a bearish technical signal amid neutral oscillators. The ETF's lower 0.15% expense ratio compared to QQQ attracts long-term growth investors, while recent Nasdaq-100 inclusion of SpaceX (1% weighting) adds diversification. Support levels cluster near $285-$283, with resistance at $288-$292.
Outlook remains tied to tech sector performance, with AI infrastructure spending by holdings like Amazon ($200B annual CapEx guidance) as a key catalyst. Risks include stretched valuations and rising AI competition. The bearish technical bias suggests near-term consolidation, but the fund's cost efficiency supports long-term growth exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
